Up to USD 150,000.00 CREDIT FACILITIES AGREEMENT
Facilities Agreement • February 28th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type
Filed
February 28th, 2020
Company
Industry
WHEREAS the Company shall undertake (i) the commercial development of the patents Lauflamide and its enantiomers, the method for the preparation of the same and the therapeutic uses thereof; Phacetoperane for the treatment of attention-deficit hyperactivity disorder; and the use of iron for the treatment of attention deficit hyperactivity disorder; as well as (ii) the securement of the patents for the medicaments Quinoleine, Tryptamine and Aminoquinoaxaline;

Second Amendment Agreement to Assignment and transfer agreement
Second Amendment Agreement • February 28th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type
Filed
February 28th, 2020
Company
Industry

convertible Loan AGREEMENT
Loan Agreement • February 28th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type
Filed
February 28th, 2020
Company
Industry

Amendment Agreement to Assignment and transfer agreement
Amendment Agreement • February 28th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type
Filed
February 28th, 2020
Company
Industry

Assignment and transfer agreement
Assignment and Transfer Agreement • February 28th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type
Filed
February 28th, 2020
Company
Industry

License and Development Agreement “Agreement” between
License and Development Agreement • February 28th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type
Filed
February 28th, 2020
Company
Industry

0001213900-20-005070 Sample Contracts

Filter & Search